Biotics and the Gut Barrier: Comparison
View Latest Version
Please note this is a comparison between Version 5 by Conner Chen and Version 4 by Conner Chen.

Increased gut permeability is suggested to be involved in the pathogenesis of a growing number of disorders. The altered intestinal barrier and the subsequent translocation of bacteria or bacterial products into the internal milieu of the human body induce the inflammatory state. Gut microbiota maintains intestinal epithelium integrity. Since dysbiosis contributes to increased gut permeability, the interventions that change the gut microbiota and correct dysbiosis are suggested to also restore intestinal barrier function

  • gut barrier
  • microbiota
  • biotics
  • probiotics
  • prebiotics
  • synbiotics
Please wait, diff process is still running!

References

  1. Takiishi, T.; Fenero, C.I.M.; Câmara, N.O.S. Intestinal Barrier and Gut Microbiota: Shaping Our Immune Responses throughout Life. Tissue Barriers 2017, 5, e1373208.
  2. Vancamelbeke, M.; Vermeire, S. The Intestinal Barrier: A Fundamental Role in Health and Disease. Expert Rev. Gastroenterol. Hepatol. 2017, 11, 821–834.
  3. Buckley, A.; Turner, J.R. Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease. Cold Spring Harb. Perspect. Biol. 2018, 10, a029314.
  4. Yang, M.; Khoukaz, L.; Qi, X.; Kimchi, E.T.; Staveley-O’carroll, K.F.; Li, G. Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment. Biomedicines 2021, 9, 1893.
  5. Pickard, J.M.; Zeng, M.Y.; Caruso, R.; Núñez, G. Gut Microbiota: Role in Pathogen Colonization, Immune Responses, and Inflammatory Disease. Immunol. Rev. 2017, 279, 70–89.
  6. Iacob, S.; Iacob, D.G.; Luminos, L.M. Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats. Front. Microbiol. 2019, 10, 3328.
  7. Hemarajata, P.; Versalovic, J. Effects of Probiotics on Gut Microbiota: Mechanisms of Intestinal Immunomodulation and Neuromodulation. Ther. Adv. Gastroenterol. 2013, 6, 39.
  8. Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; et al. Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics Consensus Statement on the Scope and Appropriate Use of the Term Probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514.
  9. Guiné, R.P.F.; Florença, S.G.; Barroca, M.J.; Anjos, O. The Link between the Consumer and the Innovations in Food Product Development. Foods 2020, 9, 1317.
  10. Jackson, S.A.; Schoeni, J.L.; Vegge, C.; Pane, M.; Stahl, B.; Bradley, M.; Goldman, V.S.; Burguière, P.; Atwater, J.B.; Sanders, M.E. Improving End-User Trust in the Quality of Commercial Probiotic Products. Front. Microbiol. 2019, 10, 739.
  11. Fijan, S. Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature. Int. J. Environ. Res. Public Health 2014, 11, 4745.
  12. Grujović, M.Ž.; Mladenović, K.G.; Semedo-Lemsaddek, T.; Laranjo, M.; Stefanović, O.D.; Kocić-Tanackov, S.D. Advantages and Disadvantages of Non-Starter Lactic Acid Bacteria from Traditional Fermented Foods: Potential Use as Starters or Probiotics. Compr. Rev. Food Sci. Food Saf. 2022, 1–31.
  13. Marco, M.L.; Sanders, M.E.; Gänzle, M.; Arrieta, M.C.; Cotter, P.D.; De Vuyst, L.; Hill, C.; Holzapfel, W.; Lebeer, S.; Merenstein, D.; et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus Statement on Fermented Foods. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 196–208.
  14. Hoffmann, D.E.; Fraser, C.M.; Palumbo, F.; Ravel, J.; Rowthorn, V.; Schwartz, J. Probiotics: Achieving a Better Regulatory Fit. Food Drug Law J. 2014, 69, 237.
  15. Žuntar, I.; Petric, Z.; Kovacevíc, D.B.; Putnik, P. Safety of Probiotics: Functional Fruit Beverages and Nutraceuticals. Foods 2020, 9, 947.
  16. Binnendijk, K.H.; Rijkers, G.T. What Is a Health Benefit? An Evaluation of EFSA Opinions on Health Benefits with Reference to Probiotics. Benef. Microbes 2013, 4, 223–230.
  17. Markowiak, P.; Ślizewska, K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients 2017, 9, 1021.
  18. Binda, S.; Hill, C.; Johansen, E.; Obis, D.; Pot, B.; Sanders, M.E.; Tremblay, A.; Ouwehand, A.C. Criteria to Qualify Microorganisms as “Probiotic” in Foods and Dietary Supplements. Front. Microbiol. 2020, 11, 1662.
  19. Kwoji, I.D.; Aiyegoro, O.A.; Okpeku, M.; Adeleke, M.A. Multi-Strain Probiotics: Synergy among Isolates Enhances Biological Activities. Biology 2021, 10, 322.
  20. Anderson, R.C.; Cookson, A.L.; McNabb, W.C.; Park, Z.; McCann, M.J.; Kelly, W.J.; Roy, N.C. Lactobacillus Plantarum MB452 Enhances the Function of the Intestinal Barrier by Increasing the Expression Levels of Genes Involved in Tight Junction Formation. BMC Microbiol. 2010, 10, 1–11.
  21. Zheng, J.; Wittouck, S.; Salvetti, E.; Franz, C.M.A.P.; Harris, H.M.B.; Mattarelli, P.; O’toole, P.W.; Pot, B.; Vandamme, P.; Walter, J.; et al. A Taxonomic Note on the Genus Lactobacillus: Description of 23 Novel Genera, Emended Description of the Genus Lactobacillus Beijerinck 1901, and Union of Lactobacillaceae and Leuconostocaceae. Int. J. Syst. Evol. Microbiol. 2020, 70, 2782–2858.
  22. Ogrodowczyk, A.M.; Drabińska, N. Crossroad of Tradition and Innovation—The Application of Lactic Acid Fer-mentation to Increase the Nutritional and Health-Promoting Potential of Plant-Based Food Products—A Review. Pol. J. Food Nutr. Sci. 2021, 71, 107–134.
  23. Yi, H.; Wang, L.; Xiong, Y.; Wang, Z.; Qiu, Y.; Wen, X.; Jiang, Z.; Yang, X.; Ma, X. Lactobacillus Reuteri LR1 Improved Expression of Genes of Tight Junction Proteins via the MLCK Pathway in IPEC-1 Cells during Infection with Enter-otoxigenic Escherichia Coli K88. Mediat. Inflamm. 2018, 2018, 6434910.
  24. Montalto, M.; Maggiano, N.; Ricci, R.; Curigliano, V.; Santoro, L.; Di Nicuolo, F.; Vecchio, F.M.; Gasbarrini, A.; Gasbarrini, G. Lactobacillus Acidophilus Protects Tight Junctions from Aspirin Damage in HT-29 Cells. Digestion 2004, 69, 225–228.
  25. Blackwood, B.P.; Yuan, C.Y.; Wood, D.R.; Nicolas, J.D.; Grothaus, J.S.; Hunter, C.J. Probiotic Lactobacillus Species Strengthen Intestinal Barrier Function and Tight Junction Integrity in Experimental Necrotizing Enterocolitis. J. Probiotics Health 2017, 5, 2329–8901.
  26. Kaur, S.; Vaishnavi, C.; Ray, P.; Singh, M.; Kochhar, R.; Kaur, S.; Vaishnavi, C.; Ray, P.; Singh, M.; Kochhar, R. Pre-liminary Investigation on the Effect of Lactobacillus and Epidermal Growth Factor on Tight Junction Proteins in Experimental Clostridium Difficile Infection. Adv. Microbiol. 2014, 4, 425–435.
  27. Nii, T.; Jirapat, J.; Isobe, N.; Yoshimura, Y. Effects of Oral Administration of Lactobacillus Reuteri on Mucosal Barrier Function in the Digestive Tract of Broiler Chicks. J. Poult. Sci. 2020, 57, 67–76.
  28. Wang, Y.; Yan, X.; Zhang, W.; Liu, Y.; Han, D.; Teng, K.; Ma, Y. Lactobacillus Casei Zhang Prevents Jejunal Epithelial Damage to Early-Weaned Piglets Induced by Escherichia Coli K88 via Regulation of Intestinal Mucosal Integrity, Tight Junction Proteins and Immune Factor Expression. J. Microbiol. Biotechnol. 2019, 29, 863–876.
  29. Francavilla, R.; Miniello, V.; Magistà, A.M.; De Canio, A.; Bucci, N.; Gagliardi, F.; Lionetti, E.; Castellaneta, S.; Polimeno, L.; Peccarisi, L.; et al. A Randomized Controlled Trial of Lactobacillus GG in Children with Functional Abdominal Pain. Pediatrics 2010, 126, 1445–1452.
  30. Mujagic, Z.; De Vos, P.; Boekschoten, M.V.; Govers, C.; Pieters, H.J.H.M.; De Wit, N.J.W.; Bron, P.A.; Masclee, A.A.M.; Troost, F.J. The Effects of Lactobacillus Plantarum on Small Intestinal Barrier Function and Mucosal Gene Transcription; a Randomized Double-Blind Placebo Controlled Trial. Sci. Rep. 2017, 7, 40128.
  31. Jungersen, M.; Wind, A.; Johansen, E.; Christensen, J.E.; Stuer-Lauridsen, B.; Eskesen, D. The Science behind the Pro-biotic Strain Bifidobacterium Animalis Subsp. Lactis BB-12®. Microorganisms 2014, 2, 92–110.
  32. Zhao, L.; Xie, Q.; Etareri Evivie, S.; Liu, D.; Dong, J.; Ping, L.; Liu, F.; Li, B.; Huo, G. Bifidobacterium Dentium N8 with Potential Probiotic Characteristics Prevents LPS-Induced Intestinal Barrier Injury by Alleviating the Inflammatory Response and Regulating the Tight Junction in Caco-2 Cell Monolayers. Food Funct. 2021, 12, 7171–7184.
  33. Hsieh, C.Y.; Osaka, T.; Moriyama, E.; Date, Y.; Kikuchi, J.; Tsuneda, S. Strengthening of the Intestinal Epithelial Tight Junction by Bifidobacterium Bifidum. Physiol. Rep. 2015, 3, e12327.
  34. Al-Sadi, R.; Nighot, P.; Nighot, M.; Haque, M.; Rawat, M.; Ma, T.Y. Lactobacillus Acidophilus Induces a Strain-Specific and Toll-Like Receptor 2–Dependent Enhancement of Intestinal Epithelial Tight Junction Barrier and Protection Against Intestinal Inflammation. Am. J. Pathol. 2021, 191, 872–884.
  35. Bergmann, K.R.; Liu, S.X.L.; Tian, R.; Kushnir, A.; Turner, J.R.; Li, H.L.; Chou, P.M.; Weber, C.R.; De Plaen, I.G. Bifidobacteria Stabilize Claudins at Tight Junctions and Prevent Intestinal Barrier Dysfunction in Mouse Necrotizing Enterocolitis. Am. J. Pathol. 2013, 182, 1595.
  36. Ling, X.; Linglong, P.; Weixia, D.; Hong, W. Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model. PLoS ONE 2016, 11, e0161635.
  37. Sonnenborn, U.; Schulze, J. The Non-Pathogenic Escherichia Coli Strain Nissle 1917—Features of a Versatile Probiotic. Microb. Ecol. Health Dis. 2009, 21, 122–158.
  38. Lu, Z.; Ding, L.; Lu, Q.; Chen, Y.-H. Claudins in intestines: Distribution and functional significance in health and diseases. Tissue Barriers 2013, 1, e24978.
  39. Zyrek, A.A.; Cichon, C.; Helms, S.; Enders, C.; Sonnenborn, U.; Schmidt, M.A. Molecular Mechanisms Underlying the Probiotic Effects of Escherichia Coli Nissle 1917 Involve ZO-2 and PKCzeta Redistribution Resulting in Tight Junction and Epithelial Barrier Repair. Cell. Microbiol. 2007, 9, 804–816.
  40. Schultz, M. Clinical Use of E. coli Nissle 1917 in Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2008, 14, 1012–1018.
  41. Alvarez, C.S.; Giménez, R.; Cañas, M.A.; Vera, R.; Díaz-Garrido, N.; Badia, J.; Baldomà, L. Extracellular Vesicles and Soluble Factors Secreted by Escherichia Coli Nissle 1917 and ECOR63 Protect against Enteropathogenic E. Coli-Induced Intestinal Epithelial Barrier Dysfunction. BMC Microbiol. 2019, 19, 166.
  42. Helmy, Y.A.; Kassem, I.I.; Kumar, A.; Rajashekara, G. In Vitro Evaluation of the Impact of the Probiotic E. Coli Nissle 1917 on Campylobacter Jejuni’s Invasion and Intracellular Survival in Human Colonic Cells. Front. Microbiol. 2017, 8, 1588.
  43. Hering, N.A.; Richter, J.F.; Fromm, A.; Wieser, A.; Hartmann, S.; Günzel, D.; Bücker, R.; Fromm, M.; Schulzke, J.D.; Troeger, H. TcpC Protein from E. Coli Nissle Improves Epithelial Barrier Function Involving PKCζ and ERK1/2 Signaling in HT-29/B6 Cells. Mucosal Immunol. 2013, 7, 369–378.
  44. Ukena, S.N.; Singh, A.; Dringenberg, U.; Engelhardt, R.; Seidler, U.; Hansen, W.; Bleich, A.; Bruder, D.; Franzke, A.; Rogler, G.; et al. Probiotic Escherichia Coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity. PLoS ONE 2007, 2, e1308.
  45. Elshaghabee, F.M.F.; Rokana, N.; Gulhane, R.D.; Sharma, C.; Panwar, H. Bacillus as Potential Probiotics: Status, Concerns, and Future Perspectives. Front. Microbiol. 2017, 8, 1490.
  46. Rhayat, L.; Maresca, M.; Nicoletti, C.; Perrier, J.; Brinch, K.S.; Christian, S.; Devillard, E.; Eckhardt, E. Effect of Bacillus Subtilis Strains on Intestinal Barrier Function and Inflammatory Response. Front. Immunol. 2019, 10, 564.
  47. Peng, M.; Liu, J.; Liang, Z. Probiotic Bacillus Subtilis CW14 Reduces Disruption of the Epithelial Barrier and Toxicity of Ochratoxin A to Caco-2 cells. Food Chem. Toxicol. 2019, 126, 25–33.
  48. Paparo, L.; Tripodi, L.; Bruno, C.; Pisapia, L.; Damiano, C.; Pastore, L.; Berni Canani, R. Protective Action of Bacillus Clausii Probiotic Strains in an in Vitro Model of Rotavirus Infection. Sci. Rep. 2020, 10, 12636.
  49. Bao, C.L.; Liu, S.Z.; Shang, Z.D.; Liu, Y.J.; Wang, J.; Zhang, W.X.; Dong, B.; Cao, Y.H. Bacillus Amyloliquefaciens TL106 Protects Mice against Enterohaemorrhagic Escherichia Coli O157:H7-Induced Intestinal Disease through Improving Immune Response, Intestinal Barrier Function and Gut Microbiota. J. Appl. Microbiol. 2021, 131, 470–484.
  50. Sheng, K.; Xu, Y.; Kong, X.; Wang, J.; Zha, X.; Wang, Y. Probiotic Bacillus Cereus Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice through Improvement of the Intestinal Barrier Function, Anti-Inflammation, and Gut Microbiota Modulation. J. Agric. Food Chem. 2021, 69, 14810–14823.
  51. Li, L.; Wang, M.; Chen, J.; Xu, Z.; Wang, S.; Xia, X.; Liu, D.; Wang, S.; Xie, C.; Wu, J.; et al. Preventive Effects of Bacillus Licheniformis on Heat Stroke in Rats by Sustaining Intestinal Barrier Function and Modulating Gut Microbiota. Front. Microbiol. 2021, 12, 548.
  52. Stevens, Y.; Pinheiro, I.; Salden, B.; Duysburgh, C.; Bolca, S.; Degroote, J.; Majdeddin, M.; Van Noten, N.; Gleize, B.; Caris-Veyrat, C.; et al. Effect of a Carotenoid-Producing Bacillus Strain on Intestinal Barrier Integrity and Systemic Delivery of Carotenoids: A Randomised Trial in Animals and Humans. J. Funct. Foods 2021, 80, 104445.
  53. Guo, P.; Zhang, K.; Ma, X.; He, P. Clostridium Species as Probiotics: Potentials and Challenges. J. Anim. Sci. Biotechnol. 2020, 11, 1–10.
  54. Liu, M.; Xie, W.; Wan, X.; Deng, T. Clostridium butyricum Protects Intestinal Barrier Function via Upregulation of Tight Junction Proteins and Activation of the Akt/MTOR Signaling Pathway in a Mouse Model of Dextran Sodium Sulfate induced Colitis. Exp. Ther. Med. 2020, 20, 1.
  55. Li, H.; Gong, Y.; Xie, Y.; Sun, Q.; Li, Y. Clostridium Butyricum Protects the Epithelial Barrier by Maintaining Tight Junction Protein Expression and Regulating Microflora in a Murine Model of Dextran Sodium Sulfate-Induced Colitis. Scand. J. Gastroenterol. 2018, 53, 1031–1042.
  56. Li, H.H.; Li, Y.P.; Zhu, Q.; Qiao, J.Y.; Wang, W.J. Dietary Supplementation with Clostridium Butyricum Helps to Improve the Intestinal Barrier Function of Weaned Piglets Challenged with Enterotoxigenic Escherichia Coli K88. J. Appl. Microbiol. 2018, 125, 964–975.
  57. Xu, L.; Sun, X.; Wan, X.; Li, K.; Jian, F.; Li, W.; Jiang, R.; Han, R.; Li, H.; Kang, X.; et al. Dietary Supplementation with Clostridium Butyricum Improves Growth Performance of Broilers by Regulating Intestinal Microbiota and Mucosal Epithelial Cells. Anim. Nutr. 2021, 7, 1105–1114.
  58. Hanchi, H.; Mottawea, W.; Sebei, K.; Hammami, R. The Genus Enterococcus: Between Probiotic Potential and Safety Concerns-an Update. Front. Microbiol. 2018, 9, 1791.
  59. Yang, S.C.; Lin, C.H.; Sung, C.T.; Fang, J.Y. Antibacterial Activities of Bacteriocins: Application in Foods and Pharmaceuticals. Front. Microbiol. 2014, 5, 241.
  60. Lodemann, U.; Strahlendorf, J.; Schierack, P.; Klingspor, S.; Aschenbach, J.R.; Martens, H. Effects of the Probiotic Enterococcus Faecium and Pathogenic Escherichia Coli Strains in a Pig and Human Epithelial Intestinal Cell Model. Scientifica 2015, 2015, 235184.
  61. He, Y.; Yang, Q.; Tian, L.; Zhang, Z.; Qiu, L.; Tao, X.; Wei, H. Protection of Surface Layer Protein from Enterococcus Faecium WEFA23 against Listeria Monocytogenes CMCC54007 Infection by Modulating Intestinal Permeability and Immunity. Appl. Microbiol. Biotechnol. 2021, 105, 4269–4284.
  62. He, W.; Ni, W.; Zhao, J. Enterococcus Faecium Alleviates Gut Barrier Injury in C57BL/6 Mice with Dextran Sulfate Sodium-Induced Ulcerative Colitis. Gastroenterol. Res. Pract. 2021, 2021, 2683465.
  63. Wu, Y.; Zhen, W.; Geng, Y.; Wang, Z.; Guo, Y. Pretreatment with Probiotic Enterococcus Faecium NCIMB 11181 Ameliorates Necrotic Enteritis-Induced Intestinal Barrier Injury in Broiler Chickens. Sci. Rep. 2019, 9, 10256.
  64. Terciolo, C.; Dapoigny, M.; Andre, F. Beneficial Effects of Saccharomyces Boulardii CNCM I-745 on Clinical Disorders Associated with Intestinal Barrier Disruption. Clin. Exp. Gastroenterol. 2019, 12, 67.
  65. Dong, J.P.; Zheng, Y.; Wu, T.; He, Q.; Teng, G.G.; Wang, H.H. Protective Effect of Saccharomyces Boulardii on Intestinal Mucosal Barrier of Dextran Sodium Sulfate-Induced Colitis in Mice. Chin. Med. J. 2019, 132, 1951–1958.
  66. Li, B.; Zhang, H.; Shi, L.; Li, R.; Luo, Y.; Deng, Y.; Li, S.; Li, R.; Liu, Z. Saccharomyces Boulardii Alleviates DSS-Induced Intestinal Barrier Dysfunction and Inflammation in Humanized Mice. Food Funct. 2022, 13, 102–112.
  67. Justino, P.F.C.; Franco, A.X.; Pontier-Bres, R.; Monteiro, C.E.S.; Barbosa, A.L.R.; Souza, M.H.L.P.; Czerucka, D.; Soares, P.M.G. Modulation of 5-Fluorouracil Activation of Toll-like/MyD88/NF-ΚB/MAPK Pathway by Saccharomyces Boulardii CNCM I-745 Probiotic. Cytokine 2020, 125, 154791.
  68. Nébot-Vivinus, M.; Harkat, C.; Bzioueche, H.; Cartier, C.; Plichon-Dainese, R.; Moussa, L.; Eutamene, H.; Pishvaie, D.; Holowacz, S.; Seyrig, C.; et al. Multispecies Probiotic Protects Gut Barrier Function in Experimental Models. World J. Gastroenterol. WJG 2014, 20, 6832.
  69. Chen, X.; Chen, W.; Ci, W.; Zheng, Y.; Han, X.; Huang, J.; Zhu, J. Effects of Dietary Supplementation with Lactobacillus acidophilus and Bacillus subtilis on Mucosal Immunity and Intestinal Barrier Are Associated with Its Modulation of Gut Metabolites and Microbiota in Late-Phase Laying Hens. Probiotics Antimicrob. Proteins 2022, 1–13.
  70. Sharma, R.; Garg, P.; Kumar, P.; Bhatia, S.K.; Kulshrestha, S. Microbial Fermentation and Its Role in Quality Im-provement of Fermented Foods. Fermentation 2020, 6, 106.
  71. Terpou, A.; Papadaki, A.; Lappa, I.K.; Kachrimanidou, V.; Bosnea, L.A.; Kopsahelis, N. Probiotics in Food Systems: Significance and Emerging Strategies Towards Improved Viability and Delivery of Enhanced Beneficial Value. Nutrients 2019, 11, 1591.
  72. Lau, S.W.; Chong, A.Q.; Chin, N.L.; Talib, R.A.; Basha, R.K. Sourdough Microbiome Comparison and Benefits. Microorganisms 2021, 9, 1355.
  73. Dimidi, E.; Cox, S.R.; Rossi, M.; Whelan, K. Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease. Nutrients 2019, 11, 1806.
  74. Pessione, E.; Cirrincione, S. Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines. Front. Microbiol. 2016, 7, 876.
  75. Santos, A.; San Mauro, M.; Sanchez, A.; Torres, J.M.; Marquina, D. The Antimicrobial Properties of Different Strains of Lactobacillus spp. Isolated from Kefir. Syst. Appl. Microbiol. 2003, 26, 434–437.
  76. Jeong, Y.J.; Kim, H.E.; Han, S.J.; Choi, J.S. Antibacterial and Antibiofilm Activities of Cinnamon Essential Oil Nanoemulsion against Multi-Species Oral Biofilms. Sci. Rep. 2021, 11, 1–8.
  77. Kocot, A.M.; Wróblewska, B. Fermented Products and Bioactive Food Compounds as a Tool to Activate Autophagy and Promote the Maintenance of the Intestinal Barrier Function. Trends Food Sci. Technol. 2021, 118, 905–919.
  78. Dudkiewicz, A.; Masmejean, L.; Arnaud, C.; Onarinde, B.A.; Sundara, R.; Pour-Taghi Anvarian, A.H.; Tucker, N. Ap-proaches for Improvement in Digestive Survival of Probiotics, a Comparative Study. Pol. J. Food Nutr. Sci. 2020, 70, 265–273.
  79. Putt, K.K.; Pei, R.; White, H.M.; Bolling, B.W. Yogurt Inhibits Intestinal Barrier Dysfunction in Caco-2 Cells by In-creasing Tight Junctions. Food Funct. 2017, 8, 406–414.
  80. Cheng, Y.; Wu, T.; Tang, S.; Liang, F.; Fang, Y.; Cao, W.; Pan, S.; Xu, X. Fermented Blueberry Pomace Ameliorates Intestinal Barrier Function through the NF-ΚB-MLCK Signaling Pathway in High-Fat Diet Mice. Food Funct. 2020, 11, 3167–3179.
  81. Gibson, G.R.; Roberfroid, M.B. Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics. J. Nutr. 1995, 125, 1401–1412.
  82. Gibson, G.R.; Hutkins, R.; Sanders, M.E.; Prescott, S.L.; Reimer, R.A.; Salminen, S.J.; Scott, K.; Stanton, C.; Swanson, K.S.; Cani, P.D.; et al. Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Prebiotics. Nat. Rev. Gastroenterol. Hepatol. 2017, 14, 491–502.
  83. Stoidis, C.N.; Misiakos, E.P.; Patapis, P.; Fotiadis, C.I.; Spyropoulos, B.G. Potential Benefits of Pro- and Prebiotics on Intestinal Mucosal Immunity and Intestinal Barrier in Short Bowel Syndrome. Nutr. Res. Rev. 2011, 24, 21–30.
  84. Drabińska, N.; Zieliński, H.; Krupa-Kozak, U. Technological Benefits of Inulin-Type Fructans Application in Glu-ten-Free Products—A Review. Trends Food Sci. Technol. 2016, 56, 149–157.
  85. Drabińska, N.; Rosell, C.M.; Krupa-Kozak, U. Inulin-Type Fructans Application in Gluten-Free Products: Functionality and Health Benefits. In Bioactive Molecules in Food; Mérillon, J.-M., Ramawat, K.G., Eds.; Springer International Publishing: Cham, Switzerland, 2017; pp. 1–40. ISBN 978-3-319-54528-8.
  86. Guarner, F. Studies with Inulin-Type Fructans on Intestinal Infections, Permeability, and Inflammation. J. Nutr. 2007, 137, 2568S–2571S.
  87. Wongkrasant, P.; Pongkorpsakol, P.; Ariyadamrongkwan, J.; Meesomboon, R.; Satitsri, S.; Pichyangkura, R.; Barrett, K.E.; Muanprasat, C. A Prebiotic Fructo-Oligosaccharide Promotes Tight Junction Assembly in Intestinal Epithelial Cells via an AMPK-Dependent Pathway. Biomed. Pharmacother. 2020, 129, 110415.
  88. Uerlings, J.; Schroyen, M.; Willems, E.; Tanghe, S.; Bruggeman, G.; Bindelle, J.; Everaert, N. Differential Effects of Inulin or Its Fermentation Metabolites on Gut Barrier and Immune Function of Porcine Intestinal Epithelial Cells. J. Funct. Foods 2020, 67, 103855.
  89. Cani, P.D.; Possemiers, S.; Van de Wiele, T.; Guiot, Y.; Everard, A.; Rottier, O.; Geurts, L.; Naslain, D.; Neyrinck, A.; Lambert, D.M.; et al. Changes in Gut Microbiota Control Inflammation in Obese Mice through a Mechanism Involving GLP-2-Driven Improvement of Gut Permeability. Gut 2009, 58, 1091–1103.
  90. Matsumoto, K.; Ichimura, M.; Tsuneyama, K.; Moritoki, Y.; Tsunashima, H.; Omagari, K.; Hara, M.; Yasuda, I.; Miyakawa, H.; Kikuchi, K. Fructo-Oligosaccharides and Intestinal Barrier Function in a Methionine–Choline-Deficient Mouse Model of Nonalcoholic Steatohepatitis. PLoS ONE 2017, 12, e0175406.
  91. Carvalho, P.L.A.; Andrade, M.E.R.; Trindade, L.M.; Leocádio, P.C.L.; Alvarez-Leite, J.I.; Dos Reis, D.C.; Cassali, G.D.; Dos Santos Martins, F.; Fernandes, S.O.A.; Peluzio, M.D.C.G.; et al. Prophylactic and Therapeutic Supplementation Using Fructo-Oligosaccharide Improves the Intestinal Homeostasis after Mucositis Induced by 5-Fluorouracil. Biomed. Pharmacother. 2021, 133, 111012.
  92. Beisner, J.; Filipe Rosa, L.; Kaden-Volynets, V.; Stolzer, I.; Günther, C.; Bischoff, S.C. Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides. Front. Immunol. 2021, 12, 678360.
  93. Grancieri, M.; Costa, N.M.B.; Tostes, M.D.G.V.; De Oliveira, D.S.; De Carvalho Nunes, L.; De Nadai Marcon, L.; Veridiano, T.A.; Viana, M.L. Yacon Flour (Smallanthus Sonchifolius) Attenuates Intestinal Morbidity in Rats with Colon Cancer. J. Funct. Foods 2017, 37, 666–675.
  94. Verediano, T.A.; Viana, M.L.; Das Graças Vaz Tostes, M.; De Oliveira, D.S.; De Carvalho Nunes, L.; Costa, N.M.B. Yacón (Smallanthus sonchifolius) Prevented Inflammation, Oxidative Stress, and Intestinal Alterations in an Animal Model of Colorectal Carcinogenesis. J. Sci. Food Agric. 2020, 100, 5442–5449.
  95. Olguin, F.; Araya, M.; Hirsch, S.; Brunser, O.; Ayala, V.; Rivera, R.; Gotteland, M. Prebiotic Ingestion Does Not Improve Gastrointestinal Barrier Function in Burn Patients. Burns 2005, 31, 482–488.
  96. Russo, F.; Linsalata, M.; Clemente, C.; Chiloiro, M.; Orlando, A.; Marconi, E.; Chimienti, G.; Riezzo, G. Inulin-Enriched Pasta Improves Intestinal Permeability and Modifies the Circulating Levels of Zonulin and Glucagon-like Peptide 2 in Healthy Young Volunteers. Nutr. Res. 2012, 32, 940–946.
  97. Ho, J.; Nicolucci, A.C.; Virtanen, H.; Schick, A.; Meddings, J.; Reimer, R.A.; Huang, C. Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children with Type 1 Diabetes. J. Clin. Endocrinol. Metab. 2019, 104, 4427–4440.
  98. Mitchell, C.M.; Davy, B.M.; Ponder, M.A.; McMillan, R.P.; Hughes, M.D.; Hulver, M.W.; Neilson, A.P.; Davy, K.P. Prebiotic Inulin Supplementation and Peripheral Insulin Sensitivity in Adults at Elevated Risk for Type 2 Diabetes: A Pilot Randomized Controlled Trial. Nutrients 2021, 13, 3235.
  99. Cukrowska, B.; Sowińska, A.; Bierła, J.B.; Czarnowska, E.; Rybak, A.; Grzybowska-Chlebowczyk, U. Intestinal Epi-thelium, Intraepithelial Lymphocytes and the Gut Microbiota—Key Players in the Pathogenesis of Celiac Disease. World J. Gastroenterol. 2017, 23, 7505–7518.
  100. Drabińska, N.; Jarocka-Cyrta, E.; Markiewicz, L.H.; Krupa-Kozak, U. The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Glu-ten-Free Diet: Results of a Randomized, Placebo-Controlled Trial. Nutrients 2018, 10, 201.
  101. Pyle, S. 2.23—Human Gut Microbiota and the Influence of Probiotics, Prebiotics, and Micronutrients. In Comprehensive Gut Microbiota; Glibetic, M., Ed.; Elsevier: Oxford, UK, 2022; pp. 271–288. ISBN 978-0-12-822036-8.
  102. Vera, C.; Córdova, A.; Aburto, C.; Guerrero, C.; Suárez, S.; Illanes, A. Synthesis and Purification of Galac-to-Oligosaccharides: State of the Art. World J. Microbiol. Biotechnol. 2016, 32, 197.
  103. Miqdady, M.; Al Mistarihi, J.; Azaz, A.; Rawat, D. Prebiotics in the Infant Microbiome: The Past, Present, and Future. Pediatric Gastroenterol. Hepatol. Nutr. 2020, 23, 1–14.
  104. Wang, G.; Zhu, J.; Liu, L.; Yaqoob, M.U.; Pei, X.; Tao, W.; Xiao, Z.; Sun, W.; Wang, M. Optimization for Galactooli-gosaccharides Synthesis: A Potential Alternative for Gut Health and Immunity. Life Sci. 2020, 245, 117353.
  105. Akbari, P.; Fink-Gremmels, J.; Willems, R.H.A.M.; Difilippo, E.; Schols, H.A.; Schoterman, M.H.C.; Garssen, J.; Braber, S. Characterizing Microbiota-Independent Effects of Oligosaccharides on Intestinal Epithelial Cells: Insight into the Role of Structure and Size: Structure–Activity Relationships of Non-Digestible Oligosaccharides. Eur. J. Nutr. 2017, 56, 1919–1930.
  106. Barrat, E.; Michel, C.; Poupeau, G.; David-Sochard, A.; Rival, M.; Pagniez, A.; Champ, M.; Darmaun, D. Supplementation with Galactooligosaccharides and Inulin Increases Bacterial Translocation in Artificially Reared Newborn Rats. Pediatric Res. 2008, 64, 34–39.
  107. Zhong, Y.; Cai, D.; Cai, W.; Geng, S.; Chen, L.; Han, T. Protective Effect of Galactooligosaccharide-Supplemented Enteral Nutrition on Intestinal Barrier Function in Rats with Severe Acute Pancreatitis. Clin. Nutr. 2009, 28, 575–580.
  108. Yang, F.; Wei, J.D.; Lu, Y.F.; Sun, Y.L.; Wang, Q.; Zhang, R.L. Galacto-Oligosaccharides Modulate Gut Mi-crobiota Dysbiosis and Intestinal Permeability in Rats with Alcohol Withdrawal Syndrome. J. Funct. Foods 2019, 60.
  109. Arnold, J.W.; Roach, J.; Fabela, S.; Moorfield, E.; Ding, S.; Blue, E.; Dagher, S.; Magness, S.; Tamayo, R.; Bruno-Barcena, J.M.; et al. The Pleiotropic Effects of Prebiotic Galacto-Oligosaccharides on the Aging Gut. Microbiome 2021, 9, 31.
  110. Zhang, Q.; Widmer, G.; Tzipori, S. A Pig Model of the Human Gastrointestinal Tract. Gut Microbes 2013, 4, 193–200.
  111. Alizadeh, A.; Akbari, P.; Difilippo, E.; Schols, H.A.; Ulfman, L.H.; Schoterman, M.H.C.; Garssen, J.; Fink-Gremmels, J.; Braber, S. The Piglet as a Model for Studying Dietary Components in Infant Diets: Effects of Galacto-Oligosaccharides on Intestinal Functions. Br. J. Nutr. 2016, 115, 605–618.
  112. Pedersen, C.; Gallagher, E.; Horton, F.; Ellis, R.J.; Ijaz, U.Z.; Wu, H.; Jaiyeola, E.; Diribe, O.; Duparc, T.; Cani, P.D.; et al. Host-Microbiome Interactions in Human Type 2 Diabetes Following Prebiotic Fibre (Galacto-Oligosaccharide) Intake. Br. J. Nutr. 2016, 116, 1869–1877.
  113. Krumbeck, J.A.; Rasmussen, H.E.; Hutkins, R.W.; Clarke, J.; Shawron, K.; Keshavarzian, A.; Walter, J. Probiotic Bifidobacterium Strains and Galactooligosaccharides Improve Intestinal Barrier Function in Obese Adults but Show No Synergism When Used Together as Synbiotics. Microbiome 2018, 6, 121.
  114. Belorkar, S.A.; Gupta, A.K. Oligosaccharides: A Boon from Nature’s Desk. AMB Express 2016, 6, 82.
  115. Ducray, H.A.G.; Globa, L.; Pustovyy, O.; Morrison, E.; Vodyanoy, V.; Sorokulova, I. Yeast Fermentate Prebiotic Im-proves Intestinal Barrier Integrity during Heat Stress by Modulation of the Gut Microbiota in Rats. J. Appl. Microbiol. 2019, 127, 1192–1206.
  116. Hansen, C.H.F.; Larsen, C.S.; Petersson, H.O.; Zachariassen, L.F.; Vegge, A.; Lauridsen, C.; Kot, W.; Krych, Ł.; Nielsen, D.S.; Hansen, A.K. Targeting Gut Microbiota and Barrier Function with Prebiotics to Alleviate Autoimmune Mani-festations in NOD Mice. Diabetologia 2019, 62, 1689–1700.
  117. Bode, L. Human Milk Oligosaccharides: Prebiotics and Beyond. Nutr. Rev. 2009, 67, S183–S191.
  118. Robinson, R.C. Structures and Metabolic Properties of Bovine Milk Oligosaccharides and Their Potential in the De-velopment of Novel Therapeutics. Front. Nutr. 2019, 6, 50.
  119. Hamilton, X.M.K.; Ronveaux, C.C.; Rust, B.M.; Newman, J.W.; Hawley, M.; Barile, D.; Mills, D.A.; Raybould, H.E. Prebiotic Milk Oligosaccharides Prevent Development of Obese Phenotype, Impairment of Gut Permeability, and Microbial Dysbiosis in High Fat-Fed Mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2017, 312, 474–487.
  120. Hann, M.; Zeng, Y.; Zong, L.; Sakurai, T.; Taniguchi, Y.; Takagaki, R.; Watanabe, H.; Mitsuzumi, H.; Mine, Y. An-ti-Inflammatory Activity of Isomaltodextrin in a C57BL/6NCrL Mouse Model with Lipopolysaccharide-Induced Low-Grade Chronic Inflammation. Nutrients 2019, 11, 2791.
  121. Gao, L.L.; Ma, J.M.; Fan, Y.N.; Zhang, Y.N.; Ge, R.; Tao, X.J.; Zhang, M.W.; Gao, Q.H.; Yang, J.J. Lycium Barbarum Polysaccharide Combined with Aerobic Exercise Ameliorated Nonalcoholic Fatty Liver Disease through Restoring Gut Microbiota, Intestinal Barrier and Inhibiting Hepatic Inflammation. Int. J. Biol. Macromol. 2021, 183, 1379–1392.
  122. Westerbeek, E.A.M.; Van den Berg, A.; Lafeber, H.N.; Fetter, W.P.F.; Van Elburg, R.M. The Effect of Enteral Supple-mentation of a Prebiotic Mixture of Non-Human Milk Galacto-, Fructo- and Acidic Oligosaccharides on Intestinal Permeability in Preterm Infants. Br. J. Nutr. 2011, 105, 268–274.
  123. Salden, B.N.; Troost, F.J.; Wilms, E.; Truchado, P.; Vilchez-Vargas, R.; Pieper, D.H.; Jáuregui, R.; Marzorati, M.; Van de Wiele, T.; Possemiers, S.; et al. Reinforcement of Intestinal Epithelial Barrier by Arabinoxylans in Overweight and Obese Subjects: A Randomized Controlled Trial: Arabinoxylans in Gut Barrier. Clin. Nutr. 2018, 37, 471–480.
  124. Shoukat, M.; Sorrentino, A. Cereal β-Glucan: A Promising Prebiotic Polysaccharide and Its Impact on the Gut Health. Int. J. Food Sci. Technol. 2021, 56, 2088–2097.
  125. Han, F.; Fan, H.; Yao, M.; Yang, S.; Han, J. Oral Administration of Yeast β-Glucan Ameliorates Inflammation and In-testinal Barrier in Dextran Sodium Sulfate-Induced Acute Colitis. J. Funct. Foods 2017, 35, 115–126.
  126. Ewaschuk, J.B.; Johnson, I.R.; Madsen, K.L.; Vasanthan, T.; Ball, R.; Field, C.J. Barley-Derived β-Glucans Increases Gut Permeability, Ex Vivo Epithelial Cell Binding to E. Coli, and Naïve T-Cell Proportions in Weanling Pigs. J. Anim. Sci. 2012, 90, 2652–2662.
  127. Mackie, A.; Rigby, N.; Harvey, P.; Bajka, B. Increasing Dietary Oat Fibre Decreases the Permeability of Intestinal Mucus. J. Funct. Foods 2016, 26, 418–427.
  128. Skouroliakou, M.; Ntountaniotis, D.; Kastanidou, O.; Massara, P. Evaluation of Barley’s Beta-Glucan Food Fortification through Investigation of Intestinal Permeability in Healthy Adults. J. Am. Coll. Nutr. 2016, 35, 13–19.
  129. Ganda Mall, J.P.; Löfvendahl, L.; Lindqvist, C.M.; Brummer, R.J.; Keita, V.; Schoultz, I. Differential Effects of Dietary Fibres on Colonic Barrier Function in Elderly Individuals with Gastrointestinal Symptoms. Sci. Rep. 2018, 8, 13404.
  130. Ganda Mall, J.P.; Casado-Bedmar, M.; Winberg, M.E.; Brummer, R.J.; Schoultz, I.; Keita, A.V. A β-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum from Patients with Crohn’s Disease and Control Subjects. Inflamm. Bowel Dis. 2018, 24, 166–178.
  131. Mall, J.P.G.; Fart, F.; Sabet, J.A.; Lindqvist, C.M.; Nestestog, R.; Hegge, F.T.; Keita, Å.V.; Brummer, R.J.; Schoultz, I. Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial. Nutrients 2020, 12, 1954.
  132. Koch, W. Dietary Polyphenols-Important Non-Nutrients in the Prevention of Chronic Noncommunicable Diseases: A Systematic Review. Nutrients 2019, 11, 1039.
  133. Bernardi, S.; Del Bo’, C.; Marino, M.; Gargari, G.; Cherubini, A.; Andrés-Lacueva, C.; Hidalgo-Liberona, N.; Peron, G.; González-Dominguez, R.; Kroon, P.; et al. Polyphenols and Intestinal Permeability: Rationale and Future Perspectives. J. Agric. Food Chem. 2019, 68, 1816–1829.
  134. Plamada, D.; Vodnar, D.C. Polyphenols—Gut Microbiota Interrelationship: A Transition to a New Generation of Prebiotics. Nutrients 2021, 14, 137.
  135. Song, P.; Zhang, R.; Wang, X.; He, P.; Tan, L.; Ma, X. Dietary Grape-Seed Procyanidins Decreased Postweaning Diarrhea by Modulating Intestinal Permeability and Suppressing Oxidative Stress in Rats. J. Agric. Food Chem. 2011, 59, 6227–6232.
  136. Shigeshiro, M.; Tanabe, S.; Suzuki, T. Dietary Polyphenols Modulate Intestinal Barrier Defects and Inflammation in a Murine Model of Colitis. J. Funct. Foods 2013, 5, 949–955.
  137. Zhou, Y.; Ruan, Z.; Zhou, L.; Yang, Y.; Mi, S.; Deng, Z.; Yin, Y. Chlorogenic Acid Decreased Intestinal Permeability and Ameliorated Intestinal Injury in Rats via Amelioration of Mitochondrial Respiratory Chain Dysfunction. Food Sci. Biotechnol. 2016, 25, 253–260.
  138. Yuan, M.; Chen, X.; Su, T.; Zhou, Y.; Sun, X. Supplementation of Kiwifruit Polyphenol Extract Attenuates High Fat Diet Induced Intestinal Barrier Damage and Inflammation via Reshaping Gut Microbiome. Front. Nutr. 2021, 8.
  139. Guglielmetti, S.; Bernardi, S.; Del Bo’, C.; Cherubini, A.; Porrini, M.; Gargari, G.; Hidalgo-Liberona, N.; Gonzalez-Dominguez, R.; Peron, G.; Zamora-Ros, R.; et al. Effect of a Polyphenol-Rich Dietary Pattern on Intestinal Per-meability and Gut and Blood Microbiomics in Older Subjects: Study Protocol of the MaPLE Randomised Controlled Trial. BMC Geriatr. 2020, 20, 77.
  140. Peron, G.; Hidalgo-Liberona, N.; González-Domínguez, R.; Garcia-Aloy, M.; Guglielmetti, S.; Bernardi, S.; Kirkup, B.; Kroon, P.A.; Cherubini, A.; Riso, P.; et al. Exploring the Molecular Pathways behind the Effects of Nutrients and Dietary Polyphenols on Gut Microbiota and Intestinal Permeability: A Perspective on the Potential of Metabolomics and Future Clinical Applications. J. Agric. Food Chem. 2020, 68, 1780–1789.
  141. Del Bo’, C.; Bernardi, S.; Cherubini, A.; Porrini, M.; Gargari, G.; Hidalgo-Liberona, N.; González-Domínguez, R.; Zamora-Ros, R.; Peron, G.; Marino, M.; et al. A Polyphenol-Rich Dietary Pattern Improves Intestinal Permeability, Evaluated as Serum Zonulin Levels, in Older Subjects: The MaPLE Randomised Controlled Trial. Clin. Nutr. 2021, 40, 3006–3018.
  142. Rinninella, E.; Costantini, L. Polyunsaturated Fatty Acids as Prebiotics: Innovation or Confirmation? Foods 2022, 11, 146.
  143. Durkin, L.A.; Childs, C.E.; Calder, P.C. Omega-3 Polyunsaturated Fatty Acids and the Intestinal Epithelium—A Review. Foods 2021, 10, 199.
  144. Van der Merwe, L.F.; Moore, S.E.; Fulford, A.J.; Halliday, K.E.; Drammeh, S.; Young, S.; Prentice, A.M. Long-Chain PUFA Supplementation in Rural African Infants: A Randomized Controlled Trial of Effects on Gut Integrity, Growth, and Cognitive Development. Am. J. Clin. Nutr. 2013, 97, 45–57.
  145. Mokkala, K.; Pussinen, P.; Houttu, N.; Koivuniemi, E.; Vahlberg, T.; Laitinen, K. The Impact of Probiotics and N-3 Long-Chain Polyunsaturated Fatty Acids on Intestinal Permeability in Pregnancy: A Randomised Clinical Trial. Benef. Microbes 2018, 9, 199–208.
  146. Krupa-Kozak, U.; Drabińska, N. 2.21—Gut Microbiota and A Gluten-Free Diet. In Comprehensive Gut Microbiota; Glibetic, M., Ed.; Elsevier: Oxford, UK, 2022; pp. 243–255. ISBN 978-0-12-822036-8.
  147. Chiu, W.C.; Huang, Y.L.; Chen, Y.L.; Peng, H.C.; Liao, W.H.; Chuang, H.L.; Chen, J.R.; Yang, S.C. Synbiotics Reduce Ethanol-Induced Hepatic Steatosis and Inflammation by Improving Intestinal Permeability and Microbiota in Rats. Food Funct. 2015, 6, 1692–1700.
  148. Swanson, K.S.; Gibson, G.R.; Hutkins, R.; Reimer, R.A.; Reid, G.; Verbeke, K.; Scott, K.P.; Holscher, H.D.; Azad, M.B.; Delzenne, N.M.; et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 687–701.
  149. Trindade, L.M.; Martins, V.D.; Rodrigues, N.M.; Souza, E.L.S.; Martins, F.S.; Costa, G.M.F.; Almeida-Leite, C.M.; Faria, A.M.C.; Cardoso, V.N.; Maioli, T.U.; et al. Oral Administration of Simbioflora® (Synbiotic) Attenuates Intestinal Damage in a Mouse Model of 5-Fluorouracil-Induced Mucositis. Benef. Microbes 2018, 9, 477–486.
  150. Jain, P.K.; McNaught, C.E.; Anderson, A.D.G.; MacFie, J.; Mitchell, C.J. Influence of Synbiotic Containing Lactobacillus Acidophilus La5, Bifidobacterium Lactis Bb 12, Streptococcus Thermophilus, Lactobacillus Bulgaricus and Oli-gofructose on Gut Barrier Function and Sepsis in Critically Ill Patients: A Randomised Controlled Trial. Clin. Nutr. 2004, 23, 467–475.
  151. West, N.P.; Pyne, D.B.; Cripps, A.W.; Christophersen, C.T.; Conlon, M.A.; Fricker, P.A. Gut Balance, a Synbiotic Supplement, Increases Fecal Lactobacillus Paracasei but Has Little Effect on Immunity in Healthy Physically Active Individuals. Gut Microbes 2012, 3, 221–227.
  152. Ferolla, S.M.; Couto, C.A.; Costa-Silva, L.; Armiliato, G.N.A.; Pereira, C.A.S.; Martins, F.S.; Ferrari, M.D.L.A.; Vilela, E.G.; Torres, H.O.G.; Cunha, A.S.; et al. Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and An-thropometric Parameters, but Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients 2016, 8, 397.
  153. Wilms, E.; Gerritsen, J.; Smidt, H.; Besseling-Van Der Vaart, I.; Rijkers, G.T.; Fuentes, A.R.G.; Masclee, A.A.M.; Troost, F.J. Effects of Supplementation of the Synbiotic Ecologic® 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial. PLoS ONE 2016, 11, e0167775.
  154. Usami, M.; Miyoshi, M.; Kanbara, Y.; Aoyama, M.; Sakaki, H.; Shuno, K.; Hirata, K.; Takahashi, M.; Ueno, K.; Tabata, S.; et al. Effects of Perioperative Synbiotic Treatment on Infectious Complications, Intestinal Integrity, and Fecal Flora and Organic Acids in Hepatic Surgery with or without Cirrhosis. J. Parenter. Enter. Nutr. 2011, 35, 317–328.
  155. Horvath, A.; Leber, B.; Feldbacher, N.; Tripolt, N.; Rainer, F.; Blesl, A.; Trieb, M.; Marsche, G.; Sourij, H.; Stadlbauer, V. Effects of a Multispecies Synbiotic on Glucose Metabolism, Lipid Marker, Gut Microbiome Composition, Gut Permeability, and Quality of Life in Diabesity: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Eur. J. Nutr. 2020, 59, 2969–2983.
  156. Janczy, A.; Aleksandrowicz-Wrona, E.; Kochan, Z.; Malgorzewicz, S. Impact of Diet and Synbiotics on Selected Gut Bacteria and Intestinal Permeability in Individuals with Excess Body Weight—A Prospective, Randomized Study. Acta Biochim. Pol. 2020, 67, 571–578.
  157. Cosola, C.; Rocchetti, M.T.; Di Bari, I.; Acquaviva, P.M.; Maranzano, V.; Corciulo, S.; Di Ciaula, A.; Di Palo, D.M.; La Forgia, F.M.; Fontana, S.; et al. An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients. Toxins 2021, 13, 334.
  158. Salminen, S.; Collado, M.C.; Endo, A.; Hill, C.; Lebeer, S.; Quigley, E.M.M.; Sanders, M.E.; Shamir, R.; Swann, J.R.; Szajewska, H.; et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Postbiotics. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 649–667.
  159. Żółkiewicz, J.; Marzec, A.; Ruszczyński, M.; Feleszko, W. Postbiotics-A Step Beyond Pre- and Probiotics. Nutrients 2020, 12, 2189.
  160. Zhou, D.; Pan, Q.; Xin, F.Z.; Zhang, R.N.; He, C.X.; Chen, G.Y.; Liu, C.; Chen, Y.W.; Fan, J.G. Sodium Butyrate Attenuates High-Fat Diet-Induced Steatohepatitis in Mice by Improving Gut Microbiota and Gastrointestinal Barrier. World J. Gastroenterol. 2017, 23, 60–75.
  161. Jiao, W.; Zhang, Z.; Xu, Y.; Gong, L.; Zhang, W.; Tang, H.; Zeng, S.; Zhang, Q.; Sun, Z.; Liu, L.; et al. Butyric Acid Normalizes Hyperglycemia Caused by the Tacrolimus-Induced Gut Microbiota. Am. J. Transplant. 2020, 20, 2413–2424.
  162. Liu, H.; Wang, J.; He, T.; Becker, S.; Zhang, G.; Li, D.; Ma, X. Butyrate: A Double-Edged Sword for Health? Adv. Nutr. 2018, 9, 21–29.
  163. Facchin, S.; Vitulo, N.; Calgaro, M.; Buda, A.; Romualdi, C.; Pohl, D.; Perini, B.; Lorenzon, G.; Marinelli, C.; D’Incà, R.; et al. Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients with Inflammatory Bowel Disease. Neurogastroenterol. Motil. 2020, 32, e13914.
  164. Huang, X.; Oshima, T.; Tomita, T.; Fukui, H.; Miwa, H. Butyrate Alleviates Cytokine-Induced Barrier Dysfunction by Modifying Claudin-2 Levels. Biology 2021, 10, 205.
  165. Ye, J.; Lv, L.; Wu, W.; Li, Y.; Shi, D.; Fang, D.; Guo, F.; Jiang, H.; Yan, R.; Ye, W.; et al. Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-Alcoholic Steatohepatitis by Improving Gut Barrier Function, At-tenuating Inflammation and Reducing Endotoxin Levels. Front. Microbiol. 2018, 9, 1967.
  166. Peng, L.; He, Z.; Chen, W.; Holzman, I.R.; Lin, J. Effects of Butyrate on Intestinal Barrier Function in a Caco-2 Cell Monolayer Model of Intestinal Barrier. Pediatric Res. 2007, 61, 37–41.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
Video Production Service
Feedback